Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children
Authors:
- 1 August 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (8) , 1783-1787
Abstract
The pharmacokinetic characteristics of cefepime were determined after first dose (n = 35) and again under steady-state conditions (n = 31) with a group of 37 infants and children. In eight subjects, a cefepime dose given by intramuscular injection was substituted for an intravenous dose, and disposition characteristics were studied again. Study subjects ranged in age from 2.1 months to 16.4 years, and all had normal renal function. Each patient received 50 mg of cefepime/kg of body weight intravenously every 8 h, up to a total maximum individual dose of 2 g. With the exception of one study patient who received a single cefepime dose for surgical prophylaxis, the patients received cefepime for 2 to 13 days. Elimination half-life (t1/2), steady-state volume of distribution, total body clearance, and renal clearance after first dose administration averaged 1.7 h, 0.35 liter/kg, and 3.1 and 1.9 ml/min/kg, respectively. Although cefepime t1/2 and mean residence time (MRT) were slightly longer for subjects or =2 months of age. The integration of the cefepime pharmacokinetic data generated in our study with the MICs for important pathogens responsible for infections in infants and children supports the administration of a dose of 50 mg of cefepime/kg every 12 h for patients > or =2 months of age to treat infections caused by pathogens for which cefepime MICs are < or =8 mg/liter.Keywords
This publication has 26 references indexed in Scilit:
- Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporinsJournal of Antimicrobial Chemotherapy, 1995
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- CefepimeDrugs, 1994
- The Crisis in Antibiotic ResistanceScience, 1992
- Cefotaxime Dosage in Infants and ChildrenClinical Pharmacokinetics, 1992
- Safety, Tolerance, and Pharmacokinetics of Cefepime Administered Intramuscularly to Healthy SubjectsThe Journal of Clinical Pharmacology, 1990
- Clinical Pharmacokinetics in Infants and Children A ReappraisalClinical Pharmacokinetics, 1989
- A versatile computational method for the determination of areas under the curve and moment curve following multidose drug administrationInternational Journal of Bio-Medical Computing, 1988
- Classification of CephalosporinsDrugs, 1987
- Critical Analysis of “Flip-Flop” Phenomenon in Two‐Compartment Pharmacokinetic ModelJournal of Pharmaceutical Sciences, 1976